13F HOLDINGS REPORT
RA CAPITAL MANAGEMENT, L.P.
Quarter ended Q2 2023 · Filed May 15, 2023 · Accession 0001104659-23-060785
Total Value
$4.42B
Positions
59
Other Managers
0
Confidential Omitted
No
Holdings (59)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | ASCENDIS PHARMA A/S | ASND | 6,957,179 | $745.9M | 16.89% |
| 2 | VAXCYTE INC | PCVX | 7,291,254 | $273.3M | 6.19% |
| 3 | DICE THERAPEUTICS INC | 23345J104 | 7,856,612 | $225.1M | 5.10% |
| 4 | 89BIO INC | 282559103 | 11,416,948 | $173.9M | 3.94% |
| 5 | AEROVATE THERAPEUTICS INC | 008064107 | 8,263,982 | $166.7M | 3.77% |
| 6 | BIOGEN INC | BIIB | 532,892 | $148.2M | 3.35% |
| 7 | VERONA PHARMA PLC | 925050106 | 6,317,990 | $126.9M | 2.87% |
| 8 | CYTEK BIOSCIENCES INC | CTKB | 13,381,054 | $123.0M | 2.78% |
| 9 | VOR BIOPHARMA INC | VOR | 22,748,880 | $122.4M | 2.77% |
| 10 | LEGEND BIOTECH CORP | LEGN | 2,436,223 | $117.5M | 2.66% |
| 11 | TYRA BIOSCIENCES INC | TYRA | 7,236,454 | $116.3M | 2.63% |
| 12 | JANUX THERAPEUTICS INC | JANX | 8,670,644 | $104.9M | 2.38% |
| 13 | PEPGEN INC | PEPG | 8,131,952 | $99.5M | 2.25% |
| 14 | AVIDITY BIOSCIENCES INC | 05370A108 | 6,416,998 | $98.5M | 2.23% |
| 15 | RHYTHM PHARMACEUTICALS INC | RYTM | 5,516,067 | $98.4M | 2.23% |
| 16 | DAY ONE BIOPHARMACEUTICALS I | DAWN | 7,040,622 | $94.1M | 2.13% |
| 17 | BELLUS HEALTH INC NEW | 07987C204 | 12,643,574 | $91.0M | 2.06% |
| 18 | CUREVAC N V | N2451R105 | 12,245,955 | $85.4M | 1.93% |
| 19 | IMMUNOGEN INC | 45253H101 | 21,853,958 | $83.9M | 1.90% |
| 20 | WAVE LIFE SCIENCES LTD | WVE | 17,202,009 | $74.5M | 1.69% |
| 21 | INHIBRX INC | INBX | 3,853,867 | $72.7M | 1.65% |
| 22 | GERON CORP | GERN | 31,544,806 | $68.5M | 1.55% |
| 23 | COGENT COMMUNICATIONS HLDGS | COGT | 5,999,481 | $64.7M | 1.47% |
| 24 | CELLDEX THERAPEUTICS INC NEW | CLDX | 1,734,972 | $62.4M | 1.41% |
| 25 | ACRIVON THERAPEUTICS INC | ACRV | 4,810,508 | $61.0M | 1.38% |
| 26 | ITEOS THERAPEUTICS INC | 46565G104 | 4,417,259 | $60.1M | 1.36% |
| 27 | NEWAMSTERDAM PHARMA COMPANY | NAMSW | 4,000,000 | $53.0M | 1.20% |
| 28 | VIRIDIAN THERAPEUTICS INC | VRDN | 2,007,946 | $51.1M | 1.16% |
| 29 | RXSIGHT INC | RXST | 3,052,796 | $50.9M | 1.15% |
| 30 | MINERALYS THERAPEUTICS INC | MLYS | 3,178,476 | $49.8M | 1.13% |
| 31 | PLIANT THERAPEUTICS INC | PLRX | 1,762,000 | $46.9M | 1.06% |
| 32 | ENLIVEN THERAPEUTICS INC | ELVN | 2,122,465 | $46.5M | 1.05% |
| 33 | GH RESEARCH PLC | GHRS | 5,581,161 | $44.6M | 1.01% |
| 34 | ACUMEN PHARMACEUTICALS INC | ABOS | 9,770,773 | $39.7M | 0.90% |
| 35 | ELIEM THERAPEUTICS INC | CLYM | 13,150,849 | $38.1M | 0.86% |
| 36 | AN2 THERAPEUTICS INC | ANTX | 3,773,517 | $37.2M | 0.84% |
| 37 | ALPINE IMMUNE SCIENCES INC | 02083G100 | 4,688,115 | $36.2M | 0.82% |
| 38 | ACLARIS THERAPEUTICS INC | ACRS | 4,398,453 | $35.6M | 0.81% |
| 39 | ICOSAVAX INC | 45114M109 | 5,963,565 | $34.6M | 0.78% |
| 40 | FULCRUM THERAPEUTICS INC | FULC | 11,609,704 | $33.1M | 0.75% |
| 41 | HILLEVAX INC | 43157M102 | 1,760,019 | $29.1M | 0.66% |
| 42 | NKARTA INC | NKTX | 7,805,129 | $27.7M | 0.63% |
| 43 | KINNATE BIOPHARMA INC | 49705R105 | 4,264,144 | $26.7M | 0.60% |
| 44 | NANOSTRING TECHNOLOGIES | 63009R109 | 2,457,273 | $24.3M | 0.55% |
| 45 | ARS PHARMACEUTICALS INC | SPRY | 3,009,678 | $19.6M | 0.44% |
| 46 | ROCKET PHARMACEUTICALS INC | RCKTW | 1,131,775 | $19.4M | 0.44% |
| 47 | TENAYA THERAPEUTICS INC | TNYA | 6,067,483 | $17.3M | 0.39% |
| 48 | DESIGN THERAPEUTICS INC | DSGN | 2,971,231 | $17.1M | 0.39% |
| 49 | SOLID BIOSCIENCES INC | SLDB | 3,426,286 | $16.2M | 0.37% |
| 50 | WEREWOLF THERAPEUTICS INC | HOWL | 6,144,881 | $16.0M | 0.36% |
| 51 | CELCUITY INC | CELC | 1,400,001 | $14.4M | 0.32% |
| 52 | EYEPOINT PHARMACEUTICALS INC | EYPT | 3,370,506 | $9.9M | 0.22% |
| 53 | CONNECT BIOPHARMA HLDGS LTD | CNTB | 6,991,003 | $7.0M | 0.16% |
| 54 | BLACK DIAMOND THERAPEUTICS I | BDTX | 2,589,904 | $4.9M | 0.11% |
| 55 | AADI BIOSCIENCE INC | WHWK | 590,218 | $4.3M | 0.10% |
| 56 | SATSUMA PHARMACEUTICALS INC | 80405P107 | 5,914,252 | $4.1M | 0.09% |
| 57 | FUSION PHARMACEUTICALS INC | 36118A100 | 659,992 | $2.5M | 0.06% |
| 58 | NEWAMSTERDAM PHARMA COMPANY | NAMSW | 333,333 | $613,333 | 0.01% |
| 59 | ENTERA BIO LTD | ENTX | 295,966 | $343,321 | 0.01% |